— Know what they know.
Not Investment Advice
Also trades as: IXI.L (LSE) · $vol 0M

PHYOF OTC

IXICO plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -80.0% 5Y: -92.3%
$0.07
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $6.5M mcap · 72M float · 0.0006% daily turnover

Balance Sheet Trends

Total Assets
$14M +23.7% ▲
5Y CAGR: +2.7%
Total Liabilities
$2M +21.9% ▲
5Y CAGR: -6.7%
Shareholders Equity
$12M +24.0% ▲
5Y CAGR: +5.2%
Cash & Investments
$4M +97.9% ▲
5Y CAGR: -14.9%
Total Debt
$179K -43.0% ▼
5Y CAGR: -3.4%
Net Debt
-$3M -128.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$7M$6M$4M$2M$4M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$6M$4M$2M$4M
Net Receivables$3M$3M$945K$2M$2M
Inventory$0$0$0$0$0
Other Current Assets$620K$583K$626K$492K$801K
Total Current Assets$10M$9M$6M$4M$6M
Property, Plant & Equip.$1M$817K$518K$313K$167K
Goodwill & Intangibles$3M$5M$6M$6M$7M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$4M-$5M$39K$9K$255K
Total Non-Current Assets$4M$5M$7M$7M$8M
Total Assets$14M$15M$13M$11M$14M
— Liabilities —
Accounts Payable$734K$254K$86K$83K$75K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$475K$673K$0$0$0
Other Current Liabilities$1M$1M$619K$1M$2M
Total Current Liabilities$2M$2M$1M$2M$2M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$114K$33K$2K$0$15K
Total Non-Current Liabilities$633K$427K$277K$150K$45K
Total Liabilities$3M$2M$2M$2M$2M
— Equity —
Common Stock$482K$482K$484K$484K$927K
Retained Earnings-$81M-$80M-$7M$7M-$11M
Accumulated OCI$7M$7M$7M$0$0
Total Stockholders Equity$11M$12M$11M$9M$12M
Total Liabilities & Equity$14M$15M$13M$11M$14M
— Key Metrics —
Total Debt$597K$516K$387K$314K$179K
Net Debt-$6M-$5M-$4M-$1M-$3M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms